Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

Eli Lilly announced a $6 billion investment in a manufacturing campus in northern Alabama to boost production of its next-generation medicines for obesity and metabolic diseases. This project is part ...

In Huntsville, Alabama, pharma giant Eli Lilly and Company has revealed it plans to invest more than $6 billion to establish a new manufacturing facility. This is the third of four new U.S. sites ...

Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...

Eli Lilly briefly reached a $1 trillion market cap, a first for any health-care company. LLY shares traded around $1,059 as demand for GLP-1 drugs surged. Mounjaro and Zepbound generated billions in ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 diabetes. A recent trial showed the drug enabled people with both conditions to ...

Drugmaker Eli Lilly reached a $1 trillion market capitalization, the first health-care company in the world to join the exclusive club dominated by tech firms. The pharmaceutical giant's stock has ...

The booming market for weight-loss drugs has propelled Eli Lilly LLY0.50%increase; green up pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...